Your session is about to expire
← Back to Search
Educational Interventions for Osteoporosis
N/A
Waitlist Available
Led By Jacques P Brown, MD
Research Sponsored by CHU de Quebec-Universite Laval
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Female, aged 50 years and over
Participants must have a fragility or traumatic fracture of specific sites
Timeline
Screening 3 weeks
Treatment Varies
Follow Up june 2007
Awards & highlights
Study Summary
This trial will focus on improving evidence-based osteoporosis diagnosis and treatment for women 50 and older who have suffered a fragility fracture. It will compare the current situation to an optimal one and propose interventions to improve care. The effectiveness of these interventions will be evaluated using a randomized control design.
Who is the study for?
This trial is for women aged 50 or older who have had a fragility fracture, can understand the study information and consent form, agree to participate voluntarily, and are able to complete questionnaires over the phone. It excludes those already in a clinical trial for osteoporosis medication, unable to grasp the programme's purpose, or with fractures due to severe trauma or disease.Check my eligibility
What is being tested?
The ROCQ programme aims to improve osteoporosis care by evaluating current diagnosis and treatment rates after fragility fractures against an ideal scenario. Interventions include educational materials and videos for patients and healthcare professionals. The effectiveness of these interventions will be measured using a randomized control design.See study design
What are the potential side effects?
Since this trial focuses on documentation and video interventions rather than medications, traditional side effects are not expected. However, participants may experience discomfort from discussing their medical condition or changes in their management of osteoporosis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman aged 50 or older.
Select...
I have had a fracture due to weakness or injury at a specific site.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ june 2007
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~june 2007
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The average 5-year, 10-year, 15-year, and 20-year probabilities of a fragility fracture by age, site of previous fragility fracture, and type of ROCQ intervention.
The osteoporosis diagnostic rate and on the osteoporosis pharmacological treatment rate 12 months after the educational interventions
The present diagnostic and treatment rates of osteoporosis 6 months after a fragility fracture
Secondary outcome measures
Assess health utility index (EQ-5D) after a fragility fracture.
Changes of modifiable risk factors for osteoporosis 12 months after the intervention
Health care resource utilization associated with specific types of fragility fracture and recurrent fractures.
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: VideoExperimental Treatment1 Intervention
A 15-minute educational video on osteoporosis as well as written documentation on osteoporosis for the participant and the physician.
Group II: DocumentationExperimental Treatment1 Intervention
Written educational material on osteoporosis for the participant and the physician.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Video
2008
Completed Phase 3
~4790
Find a Location
Who is running the clinical trial?
CHU de Quebec-Universite LavalLead Sponsor
167 Previous Clinical Trials
104,327 Total Patients Enrolled
1 Trials studying Osteoporosis
40 Patients Enrolled for Osteoporosis
Merck Frosst Canada Ltd.Industry Sponsor
29 Previous Clinical Trials
9,577 Total Patients Enrolled
4 Trials studying Osteoporosis
648 Patients Enrolled for Osteoporosis
AmgenIndustry Sponsor
1,370 Previous Clinical Trials
1,374,858 Total Patients Enrolled
54 Trials studying Osteoporosis
547,843 Patients Enrolled for Osteoporosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can participate in phone interviews.I have had a fracture due to my cancer.I am in a clinical trial for osteoporosis medication.I am a woman aged 50 or older.I have a fracture from an injury in a specific part of my body.I have had a fracture due to weakness or injury at a specific site.
Research Study Groups:
This trial has the following groups:- Group 1: Documentation
- Group 2: Video
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities to participate in this research endeavor?
"Accordingly to the data on clinicaltrials.gov, this medical trial is not enrolling participants at present time. This research was initially posted in June 2003 and its last update occurred November 2017; however, there are 138 other studies that currently require volunteers."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger